Press
Newsroom
Contact
press@imprimedicine.com
Follow
Download
Press Kit
Featured articles
TechCrunch
Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology
Read More →
USA Today
ImpriMed’s Transformative, Personal Approach to Canine Cancer Treatment
Read More →
International Business Times
ImpriMed: Revolutionizing Canine Cancer Treatment with Precision and Personalization
Read More →
MedCity News
Meet the 7 startups Mayo Clinic just welcomed to its AI accelerator
Read More →
Latest Stories
Button Text
In the News
Button Text
Presentations
Button Text
Press Releases
Button Text
Scientific Publications
Button Text
Video/Podcast Interviews
Scientific Publications
ML-based sequential analysis to assist selection between VMP and RD for newly diagnosed multiple myeloma
npj Precision Oncology
Learn More →
Presentations
ImpriMed: AI-driven Personalized Medicine for Pet Cancer Care
Veterinary Cancer Society-Veterinary Society of Surgical Oncology Collaborative Conference 2023
Learn More →
Presentations
Reinventing precision medicine: from dogs to humans
Precision Medicine World Conference 2023
Learn More →
Presentations
ImpriMed Research Update
Veterinary Cancer Society Annual Conference 2022
Learn More →
Presentations
Identification of Novel Predictive Biomarkers of Anticancer Drug Responses in Canine B-Cell Lymphoma Using Targeted NGS
Veterinary Cancer Society Annual Conference 2022
Learn More →
In the News
The latest and greatest in canine oncology treatment
DVM360
Learn More →
Press Releases
ImpriMed Wins Place at the Mayo Clinic Platform_Accelerate Immersive Program
EIN Presswire
Learn More →
In the News
Get Rid of Your Cancer Treatment Frustrations
Innovative Veterinary Care Journal
Learn More →
In the News
Meet the 7 startups Mayo Clinic just welcomed to its AI accelerator
MedCity News
Learn More →
In the News
Be sure to improve your cancer treatment outcomes
Innovative Veterinary Care Journal
Learn More →
Press Releases
40 Under 40 in Cancer Class of 2022 Recognizes Dr. Sungwon Lim, ImpriMed CEO & Co-Founder
EIN Presswire
Learn More →
In the News
Early leukemia and lymphoma remissions in cats and dogs
Innovative Veterinary Care Journal
Learn More →
In the News
Thought Leaders in Artificial Intelligence: ImpriMed CEO Sungwon Lim (Part 3)
One Million by One Million
Learn More →
In the News
Thought Leaders in Artificial Intelligence: ImpriMed CEO Sungwon Lim (Part 2)
One Million by One Million
Learn More →
In the News
Thought Leaders in Artificial Intelligence: ImpriMed CEO Sungwon Lim (Part 1)
One Million by One Million
Learn More →
In the News
Technological advancement makes cancer treatment easier
Innovative Veterinary Care Journal
Learn More →
Press Releases
ImpriMed Presents New Research Findings at The Veterinary Cancer Society (VCS) Mid-Year Conference
EIN Presswire
Learn More →
In the News
Novel veterinary oncologic treatments and diagnostics
dvm360
Learn More →
Previous
Next
Webflow Homepage
Veterinary Precision Medicine
Human Precision Medicine
Ex Vivo CRO Services for Pharma
About Us
Careers
Events
Press
Language
日本語 (Japanese)
English (International)
日本語 (Japanese)
English (International)
Contact Us